You just read:

NLS Pharma Unveils Positive Phase 2 Data For NLS-1 (mazindol CR) In Adults With ADHD, Demonstrating Significant Improvement In Symptoms

News provided by

NLS Pharma Group

May 31, 2017, 07:00 ET